DYN Dyne Therapeutics, Inc.
Healthcare$17.37+0.00%ClosedMarket Cap: $2.87B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
3.31
P/S
0.00
EV/EBITDA
-4.84
DCF Value
$6.74
FCF Yield
-16.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-58.3%
ROA
-41.8%
ROIC
-45.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-125.3M | $-120.9M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-116.1M | $-112.0M | $— | — |
| FY null | $0.00 | -Infinity% | $-468.2M | $-446.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-113.9M | $-108.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-115.8M | $-110.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-122.4M | $-115.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-97.1M | $-89.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-343.9M | $-317.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-105.7M | $-97.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-72.0M | $-65.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-69.2M | $-65.6M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-67.7M | $-66.6M | $-1.09 | — |